These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 24516610)

  • 1. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin.
    Federici C; Petrucci F; Caimi S; Cesolini A; Logozzi M; Borghi M; D'Ilio S; Lugini L; Violante N; Azzarito T; Majorani C; Brambilla D; Fais S
    PLoS One; 2014; 9(2):e88193. PubMed ID: 24516610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmental pH is a key factor for exosome traffic in tumor cells.
    Parolini I; Federici C; Raggi C; Lugini L; Palleschi S; De Milito A; Coscia C; Iessi E; Logozzi M; Molinari A; Colone M; Tatti M; Sargiacomo M; Fais S
    J Biol Chem; 2009 Dec; 284(49):34211-22. PubMed ID: 19801663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
    Luciani F; Spada M; De Milito A; Molinari A; Rivoltini L; Montinaro A; Marra M; Lugini L; Logozzi M; Lozupone F; Federici C; Iessi E; Parmiani G; Arancia G; Belardelli F; Fais S
    J Natl Cancer Inst; 2004 Nov; 96(22):1702-13. PubMed ID: 15547183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
    De Milito A; Canese R; Marino ML; Borghi M; Iero M; Villa A; Venturi G; Lozupone F; Iessi E; Logozzi M; Della Mina P; Santinami M; Rodolfo M; Podo F; Rivoltini L; Fais S
    Int J Cancer; 2010 Jul; 127(1):207-19. PubMed ID: 19876915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
    Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
    Front Immunol; 2021; 12():692654. PubMed ID: 34149737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules.
    Boussadia Z; Lamberti J; Mattei F; Pizzi E; Puglisi R; Zanetti C; Pasquini L; Fratini F; Fantozzi L; Felicetti F; Fecchi K; Raggi C; Sanchez M; D'Atri S; Carè A; Sargiacomo M; Parolini I
    J Exp Clin Cancer Res; 2018 Oct; 37(1):245. PubMed ID: 30290833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors may reduce tumour resistance.
    De Milito A; Fais S
    Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma.
    Azzarito T; Venturi G; Cesolini A; Fais S
    Cancer Lett; 2015 Jan; 356(2 Pt B):697-703. PubMed ID: 25449440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
    Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
    Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures.
    Galé A; Hofmann L; Lüdi N; Hungerbühler MN; Kempf C; Heverhagen JT; von Tengg-Kobligk H; Broekmann P; Ruprecht N
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance.
    Song W; Tang Z; Shen N; Yu H; Jia Y; Zhang D; Jiang J; He C; Tian H; Chen X
    J Control Release; 2016 Jun; 231():94-102. PubMed ID: 26928530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
    Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
    Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
    Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Vermathen M; von Tengg-Kobligk H; Hungerbühler MN; Vermathen P; Ruprecht N
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
    Franke CE; Czapar AE; Patel RB; Steinmetz NF
    Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.
    Avnet S; Lemma S; Cortini M; Pellegrini P; Perut F; Zini N; Kusuzaki K; Chano T; Grisendi G; Dominici M; De Milito A; Baldini N
    Oncotarget; 2016 Sep; 7(39):63408-63423. PubMed ID: 27566564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.